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ABSTRACT
Non-integrating gene vectors, which are stably and
extrachromosomally maintained in transduced cells
would be perfect tools to support long-term expres-
sion of therapeutic genes but preserve the genomic
integrity of the cellular host. Small extrachromo-
somal plasmids share some of these ideal character-
istics but are primarily based on virus blueprints.
These plasmids are dependent on viral trans-acting
factors but they can replicate their DNA molecules
in synchrony with the chromosome of the cellular
host and segregate to daughter cells in an auto-
nomous fashion. On the basis of the concept of the
latent origin of DNA replication of Epstein-Barr
virus, oriP, we devised novel derivatives, which
exclusively rely on an artificial replication factor for
both nuclear retention and replication of plasmid
DNA. In addition, an allosteric switch regulates the
fate of the plasmid molecules, which are rapidly lost
upon addition of doxycycline. Conditional mainte-
nance of these novel plasmid vectors allows the
reversible transfer of genetic information into target
cells for the first time.
INTRODUCTION
Vectors employed for gene and immune therapy of various
human diseases are based on recombinant nucleic acids.
Most gene vectors include viral or metazoan genetic
components such as promoters and enhancers, which
provide the necessary cis-acting elements for expression of
one or more genes of therapeutic interest. In addition,
certain virus-based gene vectors also carry essential
elements involved in packaging of genetic information
into virus-like structures (1). In the recipient cell, gene
vectors can be transiently present or maintained for a long
period of time. In these cases, the genetic information is
either rapidly lost through spontaneous degradation by
cellular nucleases or maintained by integrating it into the
chromosome of the recipient cell. Because a prolonged
eﬀect of the therapeutic gene product is often preferred,
gene vectors are commonly employed, which promote
their chromosomal integration. In particular, all retro-
viruses and adeno-associated viruses integrate randomly
or at numerous potential predilections sites as proviruses
and establish a persistent state (1). Similarly, non-viral
gene vectors can also integrate chromosomally and in a
random fashion but recent reports indicate targeted gene
delivery via induced double-strand break in predetermined
gene loci (2–5). Unfortunately, all integrating vectors can
act as insertional mutagens, which might be destructive to
the transduced cell. For example, oncogenic T-cell trans-
formation was observed in a recent clinical trial with a
retroviral vector (6). This problem can be avoided with
gene vectors, which are stably maintained as extra-
chromosomal units in the recipient cell.
All extrachromosomal gene vectors are derived from
recombinant plasmids, which carry autonomous replicons
(7–9). Replicons are genetic units, which mediate initiation
of DNA replication in the context of the cellular genome
or on plasmid DNA. In metazoan cells, two extrachro-
mosomal vector systems are well known, which replicate
in synchrony with the host chromosome: oriP-based
plasmids and a non-viral vectors system called pEPI
(9,10). The plasmid replicon of Epstein-Barr virus (EBV),
oriP, is the latent origin of DNA replication of this human
herpes virus. Plasmids containing this element replicate
akin to the genome of its host cell and are maintained
extrachromosomally. Consequently, this plasmid replicon
has been exploited as recombinant gene vector (7). oriP
supports eﬃcient DNA replication in cells selected to
retain it at several copies when the viral gene product
EBNA1 (Figure 1A) is provided. Recombinant plasmids
containing oriP replicate once per cell cycle during S-
phase and are eﬃciently segregated to daughter cells (11).
Only two components, oriP in cis and EBNA1 in trans, are
required, the cell contributes everything else.
oriP consists of two essential cis-acting elements, the
family of repeats (FR) and a structure called dyad
symmetry element (DS) to both of which EBNA1 binds
sequence speciﬁcally (Figure 1B). EBNA1 recruits
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where initiation of DNA replication takes place (11). The
FR element is an array of 20 EBNA1-binding motifs
dedicated to retain oriP in the nucleus because EBNA1
tethers oriP to cellular chromatin (12,13) (Figure 1B).
Nuclear retention of oriP plasmids is considered manda-
tory for long-term plasmid maintenance and might
contribute to partitioning in each cell cycle. Thus, DS
and FR are functionally distinct elements dedicated to
DNA replication and replicon nuclear retention, respec-
tively. EBNA1 is characterized by its modular design. Its
carboxy-terminal half mediates dimerization and DNA
binding, its amino-terminal half, in particular, the two
linking regions (Figure 1A) associate with cell chromo-
somes (13) and is essential for plasmid maintenance (11).
EBNA1’s characteristics triggered an approach in
which its carboxy-terminal dimerization and DNA-
binding domain was fused to the cellular histone H1 or
HMGA1a proteins conferring chromatin binding and
association to mitotic chromosomes (14). These chimeric
proteins were functional with respect to plasmid replica-
tion and nuclear retention presumably because EBNA1
contains AT-hook domains in its linking regions (15)
similar to HMGA family members such as HMGA1a
(16,17 and references therein) and histone H1 targets the
same structural DNA motif as AT-hook domains.
HMGA1a functionally interacts with the mammalian
origin of DNA replication, ORC, (18) similar to EBNA1
(19). Targeting HMGA1a to speciﬁc sites on plasmid
DNA generates artiﬁcial origins of DNA replication,
which mediate DNA replication (18). We extended these
initial observations and designed novel synthetic plasmids,
which replicate and are retained in the nucleus of
transduced cells upon selection similar to oriP but can
be regulated at will at the level of its DNA.
MATERIAL AND METHODS
Cell lines
The HEK293 cell line is derived from primary human
embryonal kidney cells transformed with human adeno-
virus type 5 DNA (20). 293-D is a clonal derivative
established in our laboratory. Akata 27 is an EBV-
negative derivative of Akata cells, a human Burkitt
lymphoma cell line (21). Rat-1 cells are rat embryo
ﬁbroblasts (22). Cell line 143/tk
 is a human cell line
established from an osteosarcoma (23). A clonal HEK293
EBNA1 cell line was established by stable transfection of
293-D cells with two plasmids, p2816 and p2727, which
express EBNA1 and neomycin phosphotransferase,
respectively, and selection with 200mg/ml G418. A
HEK293 cell clone expressing both EBNA1 and
EBNA1:TetR was established with 293-D cells. First,
they were stably transfected with two plasmids, p2729.1
and p2727, which express EBNA1:TetR and neomycin
phosphotransferase, respectively, and selected with
200mg/ml G418. Second, the resulting EBNA1:TetR-
positive cell clone was stably transfected with p2774 and
selected with 100mg/ml hygromycin. p2774 expresses both
EBNA1 and hygromycin phosphotransferase and was a
kind gift from B. Sugden. A HEK293 cell clone which
expresses both wild-type EBNA1 and scTetR:HMGA1a
was established on the basis of HEK293 EBNA1 cells,
which were cotransfected with p3265.12 together with
p3223.9 encoding scTetR:HMGA1a and puromycin resis-
tance, respectively, and selected with 250ng/ml puro-
mycin. All clonal HEK293 derivatives were analyzed for
the expression of EBNA1, EBNA1:TetR or
scTetR:HMGA1a proteins by western blot immunostain-
ing with the monoclonal antibody 1H4 directed against
EBNA1 or a polyclonal rabbit antisera generated against
TetR(B) protein. Akata cells and all HEK293-derived cell
lines were maintained in RPMI1640 medium with 10%
fetal calf serum, 100 units of penicillin per milliliter and
100mg of streptomycin per milliliter at 378C in a 5% CO2
atmosphere. Rat-1 and 143/tk
 cells were maintained in
DMEM with all supplements.
Plasmids
Plasmids carrying oriP, hybrid oriP replicons, or synthetic
oriP-like replicons are summarized in Table 1 along with
their key features. All plasmid DNAs were prepared
with Jetstar 2.0 columns (Genomed, Lo ¨ hne, Germany).
Genetic modiﬁcation of FR and DS elements were
Figure 1. Chimeric EBNA1:TetR confers conditional plasmid maintenance. (A) Design of the trans-acting factor EBNA1:TetR. Wild-type EBNA1 with
designated functional domains and their amino acid residues is shown in comparison with the chimeric protein EBNA1:TetR composed of EBNA1’s
amino-terminal half joined via an artiﬁcial linking domain [(SG4)5] to the complete coding region of the tetR gene followed by three repeats of the motif F,
a minimal transcriptional activation domain (24). Most of the central glycine–alanin repeats (Gly-Ala-repeats) and about half of them are deleted in
EBNA1 and EBNA1:TetR, respectively, as indicated () without functional consequences (48). Western blot analysis of the parental HEK293 cell line
and its derivatives expressing EBNA1 (center lane) and EBNA1+EBNA1:TetR (right lane) was performed with antibodies directed against TetR and
EBNA1. (B) Schematic overview of the oriP replicon and the hybrid replicon plasmid tetO
20/DS
wt. The two cis-acting elements of oriP, FR and DS, carry
20 and 4 EBNA1-binding sites as indicated by the number of black circles. The hybrid replicon plasmid tetO
20/DS
wt carries an array of 20 tetO-binding
sites (red circles) to which EBNA1:TetR binds with high aﬃnity. EBNA1:TetR binds as a dimer-like EBNA1, thus these trans-acting factors are shown as
doublets. (C) The plasmids p2832 (oriP wt) and p2835 (tetO
20/DS
wt) wereseparately transfected into HEK293 cells expressing EBNA1 and EBNA1:TetR.
The cells were selected with puromycin with or without DOX (2.0mg/ml) for 8 days. Low-molecular weight DNA was isolated, linearized and digested
with DpnI to cleave unreplicated plasmid DNAs. Full-length DpnI-resistant plasmid DNA was detected by Southern blot hybridization with a radioactive
probe speciﬁc for the prokaryotic plasmid backbone. DOX had almost no eﬀect on p2832. No plasmid signal was detected when the cells had been
transfected with p2835 and kept under selection in the presence of DOX. The left lane shows p2832 (oriP wt) in the HEK293 cell line expressing EBNA1,
only. (D) HEK293 cells, which express no viral protein, EBNA1 or both EBNA1+EBNA1:TetR were transfected with two diﬀerent plasmids p3154
(oriP wt) or p3155 (tetO
20/DS
wt) encoding mRFP and puromycin resistance and selected for 4 days (day 0). The selective pressure was removed and the
cells were kept with or without DOX (2.0mg/ml) for a period of 12 days. No or only very few cells appeared to express mRFP in parental HEK293 cells
transfected with the two plasmids at that time point (top row and data not shown) indicating that they were rapidly lost in the absence of EBNA1 and
EBNA1:TetR. In EBNA1 expressing HEK293 cells transfected with p3154 (oriP wt), a fraction of cells expressed mRFP in the presence or absence of
DOX (middle row) after 12 days. HEK293 cells expressing both trans-factors and transfected with p3155 (tetO
20/DS
wt) were mRFP positive, only, when
the cells had been cultivated in the absence of DOX (bottom row).
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appropriate locations by conventional techniques. DNA
sequencing conﬁrmed the sequence composition of the
critical regions. The plasmids encoding EBNA1, EBNA1:
TetR and scTetR:HMGA1a express their trans-genes
from the immediate early human cytomegalovirus pro-
moter. The expression plasmid encoding EBNA1:TetR,
p2729.1, is based on pWHE120 (B+sB) encoding
sctTA2
i (24) in which the ﬁrst tetR allele was replaced
by the amino-terminal half of EBNA1. The expression
plasmid encoding scTetR:HMGA1a, p3265.12, is based
on pWHE120 (sB+B) encoding sctTA2 (24), in which
the triple-F domain was replaced by the entire coding
sequence of human HMGA1a (18). All plasmid DNA
sequences are available upon request.
DNA transfections
DNA transfections into HEK293 cells and derivatives
were performed with Polyfect (Qiagen, Hilden, Germany).
Cells were seeded at 50% conﬂuence into six-well cluster
plates 1day prior to transfection. For transfection, cells
were placed in OptiMEM medium (Invitrogen, Karlsruhe,
Germany) for 1h and incubated with gene vector plasmid
DNA embedded in lipid micelles (1mg DNA, 2.5ml
Polyfect per well, 100ml of RPMI1640 without supple-
ments; preincubation for 15min at room temparture)
overnight. After 1–2 days, the cells were transferred into a
13-cm cell culture dish and cultivated in the presence of
80mg/ml hygromycin, 250ng/ml puromycin or 200mg/ml
G418.
Plasmid rescue in Escherichia coli
To determine the number of plasmid copies in transfected
HEK293 cells low-molecular weight DNA was isolated
(25) and digested with DpnI to cleave unreplicated plasmid
DNAs, which retain the dam methylation pattern that
the plasmids had acquired during propagation in E. coli.
DNA (600ng) was introduced into the E. coli DH10B
strain by electroporation (1800V, 25mF, 100, 1mm gap
cuvettes, Genepulser (Biorad Laboratories Munich,
Germany). Transformants were selected on agar plates
containing 100mg/ml ampicillin. Several colonies were
picked and the DNA composition of the rescued plasmid
was conﬁrmed with restriction enzyme analysis.
Chromatin immunoprecipitation assay
and real-time PCR analysis
For chromatin immunoprecipitation experiments, nuclei
were prepared for each immunoprecipitation as described
(26). For each sample 110
7 cells were harvested, washed
with PBS and resuspended in 250ml hypotonic buﬀer A
[10mM Hepes, pH 7.9, 10mM KCl, 1.5mM MgCl2,
0.34M sucrose, 10% glycerol, 1mM DTT and protease
inhibitor mix Complete
 (Roche Diagnostics, Mannheim,
Germany)]. Cells were lysed by adding 0.04% Triton X-
100 and incubated for 10min on ice. Samples were
centrifuged (4min, 1300g,4 8C) to separate soluble
cytosolic and nucleosolic proteins from chromatin.
Nuclei were washed at a concentration of 110
8 nuclei/
ml in ice-cold buﬀer A supplemented with 200mM NaCl.
After centrifugation (1300g, 5min, 48C) nuclei were
carefully resuspended in 1ml buﬀer A. Prewarmed buﬀer
A (9ml) supplemented with 1.1% formaldehyde was
added and the nuclei crosslinked for 10min at 378C.
Fixed nuclei were washed twice with PBS/0.5% NP40,
resolved in 2.7ml LSB (10mM Hepes, pH7.9, 10mM KCl
and 1.5mM MgCl2) and lysed by adding 300ml 20%
Sarkosyl. The chromatin was transferred onto a 40ml
sucrose cushion (LSB+100mM sucrose) and centrifuged
(10min, 48C, 4000g). The supernatant was removed and
chromatin was resuspended in 2ml TE and sonicated
(Branson soniﬁer 250-D, 35% amplitude, 2min in 1s
intervals). For partial DNA digestion, 2mM CaCl2 and 8
units MNase (Roche) were added and incubated
for 10min at 378C. The reaction was stopped by adding
5mM EGTA. For immunoprecipitation, the extract was
adjusted with 1/10 volume of 11xNET (50mM Tris,
150mM NaCl, 0.5M EDTA and 0.5% NP40).
Ten microliter of polyclonal rabbit antibody directed
against TetR(B) protein or 50ml supernatant of the
Table 1. List of oriP- and oriP-like plasmids
Plasmids
a Retention element Replication element Genotypic marker Phenotypic marker
p2832 oriP wt (12.2) FR DS Puromycin None
p2835 tetO
20/FR
wt (12.0) 20xtetO DS Puromycin None
p3154 oriP wt (12.9) FR DS Puromycin mRFP
p3155 tetO
20/FR
wt (12.7) 20xtetO DS Puromycin mRFP
p3230 oriP wt (8.8) FR DS Hygromycin GFP
c
p3231 tetO
20/FR
wt (8.7) 20xtetO DS Hygromycin GFP
c
p3293 tetO
40/FR
wt (8.9) 40xtetO DS Hygromycin GFP
c
p3311 tetO
20/tetO
4 (8.7) 20xtetO 4xtetO Hygromycin GFP
c
p3315 FR
wt/tetO
4 (8.8) FR 4xtetO Hygromycin GFP
c
p3323 (pHEBNA)
b (9.0) FR DS Hygromycin None
p3333 tetO
20/tetO
4 (11.1) 20xtetO 4xtetO Hygromycin GFP
c
p3421 tetO
20/tetO
4 (8.7) 20xtetO 4xtetO opt.
d Hygromycin GFP
c
aNumbers in parentheses denote the size of the plasmids in kilo base pairs.
bPublished in Yates et al. (49).
cDestabilized d2GFP.
dOptimized (opt.) compared to p3311. p3421 and p3311 diﬀer in the distance of the two tetO pairs, which make up the DS-like element without
apparent functional diﬀerence.
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The immunoprecipitation and puriﬁcation of coprecipi-
tated DNA was performed as described (19). Real-time
PCR analysis was performed according to the manufac-
turer’s instructions using the same parameters and the
primer pair SC4 as described (19). Detailed protocols of
the chromatin immunoprecipitation experiments are
available at http://haema145.gsf.de/
Bromodeoxyuridine density transfer experiments
HEK293 cells stably transfected with either p3230 (oriP
wt) or p3421 (tetO
20/tetO
4) were incubated in cell culture
medium containing 5-bromodeoxyuridine (10mM, BrdU)
and deoxycytidine (100 mM) (27) for 16h to label newly
synthesized DNA. Total DNA was isolated from 110
7
cells, digested with BamHI and separated on CsCl equilib-
rium density gradients adjusted to the initial refractive
index of 1.403. The gradients were spun in a Beckman
SW41 rotor at 38000rpm for 48h. To measure the
incorporation of BrdU, 28 fractions were analyzed for the
distribution of total cellular and plasmid DNAs. A
quantity of 250ml fractions was collected and their
refractive index was determined. Samples were diluted,
precipitated and further analyzed by quantitative PCR
with the SC4 primer pair. Total cellular DNA was deter-
mined photometrically.
RESULTS
The prokaryotic Tet repressor fused to EBNA1 confers
plasmid maintenance
We wanted to assess whether EBNA1’s DNA-binding
domain can be replaced with a heterologous but function-
ally similar domain and constructed a chimeric DNA-
binding protein to mimic EBNA1’s function to provide
plasmid maintenance. As shown in Figure 1A and B, the
entire open reading frame of the prokaryotic DNA-
binding protein TetR(B) (28) replaced the EBNA1 DNA-
binding domain. The tetR gene product forms
homodimers similar to EBNA1 and binds to its cognate
DNA motif tetO with very high aﬃnity and speciﬁcity
(29). We established a derivative of HEK293 cells, which
stably expressed EBNA1 and the EBNA1:TetR chimera
(Figure 1A). In order to allow binding of EBNA1:TetR to
oriP, we replaced the 20 EBNA1-binding sites within FR
with an identical number of tetO sites to which TetR binds
(Figure 1B). This hybrid replicon plasmid tetO
20/DS
wt
p2835 (Table 1, Figure 1C) also carries a selectable maker
gene for puromycin resistance. The parental plasmid
p2832 is identical to p2835 except that it contains wild-
type (wt) oriP.
The plasmids p2832 (oriP wt) and p2835 (tetO
20/DS
wt)
were separately transfected into HEK293 cells, which
coexpressed both EBNA1+EBNA1:TetR. The trans-
fected cells were cultivated in the presence of selective
concentrations of puromycin with (2mg/ml) or without
doxycycline (DOX; Sigma Aldrich, Deisenhofen,
Germany) for a few days until the cells had reached
conﬂuence. As a reference, the wild-type oriP plasmid was
also introduced into HEK293 cells, which expressed
EBNA1, only, and selected with puromycin in the absence
of DOX. Low-molecular weight DNA was isolated,
linearized and cleaved with DpnI to fragment non-
replicated, input plasmid DNA, which retained the dam
methylation pattern that it had acquired during propaga-
tion in E. coli. As shown in Figure 1C, full-length DpnI-
resistant plasmid DNA was detected by Southern blot
analysis. Whereas DOX had almost no eﬀect on oriP in
HEK293 cells coexpressing EBNA1 and EBNA1:TetR, no
signal was detected with p2835 (tetO
20/DS
wt) in the
presence of DOX suggesting that DOX interfered with
plasmid maintenance in this short-term experiment. In
HEK293 cells, which express EBNA1, only, the copy
number of the wild-type oriP plasmid was considerable
higher in contrast cells, which coexpress EBNA1 and
EBNA1:TetR (Figure 1C). This observation will be
addressed below.
Next, we used two diﬀerent plasmids which encode
monomeric red ﬂuorescence protein (mRFP) (30) to
conﬁrm our initial ﬁndings. p3154 carries wild-type oriP,
whereas p3155 contains 20 tetO sites (tetO
20/DS
wt)
(Figure 1C, Table 1). Three cell lines (parental HEK293
and derivatives expressing EBNA1 or both
EBNA1+EBNA1:TetR) were transfected and selected
with puromycin for 2–4 days, only, until most of the
remaining adherent cells expressed mRFP (day 0,
Figure 1D). The selective pressure was removed and the
cells were kept in media with or without DOX for 12 days.
No or only very few cells appeared to express mRFP in
parental HEK293 cells transfected with p3154 or p3155 at
that period (Figure 1D top row and data not shown)
indicating that both plasmids were rapidly lost in the
absence of EBNA1 and EBNA1:TetR. In HEK293
EBNA1 cells transfected with p3154 (oriP wt), a fraction
of cells still expressed mRFP in the presence or absence of
doxycycline (+/ DOX in Figure 1D, middle row) after
12 days. HEK293 cells expressing both trans-factors
(EBNA1 and EBNA1:TetR) and transfected with the
hybrid replicon plasmid p3155 were mRFP positive, only,
when the cells had been cultivated in the absence of DOX;
addition of this drug led to loss of mRFP expression
(Figure 1D, bottom row). This result conﬁrmed that
maintenance of p3155 is strictly dependent on
EBNA1:TetR, which does not bind to tetO motifs in the
presence of DOX (data not shown). As a consequence,
hybrid oriP replicons cannot be maintained in the
presence of the drug.
Long-term conditional maintenance of hybrid
oriPplasmids
The amino-terminal part in the EBNA1:TetR chimera is
expected to associate to chromatin and bind to ORC,
which is essential for plasmid retention and DNA
replication, respectively. Because oriP plasmids replicate
and are stably maintained in the presence of
HMGA1a:EBNA1 (14), we argued that the chimeric
protein consisting of the coding sequence of HMGA1a
fused to TetR (scTetR:HMGA1a, Figure 2A) (18) might
be functional as well in retaining plasmid DNA with
multiple tetO sites. It was also apparent that the plasmid
PAGE 5 OF 11 Nucleic Acids Research, 2008, Vol. 36, No. 13 e83Figure 2. scTetR:HMGA1a confers conditional plasmid maintenance. (A) The trans-acting factor scTetR:HMGA1a consists of a single-chain (sc)
dimer of two tetR genes joined via an artiﬁcial linking domain (yellow) which was fused to the HMGA1a coding sequence. Western blot analysis of
the parental HEK293 cells and its derivative expressing EBNA1+scTetR:HMGA1a with TetR- and EBNA1-speciﬁc antibodies. (B)
scTetR:HMGA1a and EBNA1 mediate chromatin tethering and DNA replication, respectively. (C) DOX downregulates vector-encoded GFP
expression and causes induced loss of plasmid DNA. The oriP wt (p3230) plasmid and two hybrid replicon plasmids tetO
20/DS
wt (p3231) and tetO
40/
DS
wt (p3293) were transfected into EBNA1 and scTetR:HMGA1a expressing HEK293 cells, which were then selected with hygromycin for 19 days.
At that time point (day 0) selection was removed and the cells were further cultivated with or without DOX (2.5g/ml) for 12 days. On days 0, 4, 8
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plasmid p2835 was considerably lower in cells which
coexpressed EBNA1 and EBNA1:TetR (Figure 1C) pre-
sumably because the linking region of EBNA1 and
EBNA1:TetR (Figure 1A) caused heterotypic aggrega-
tions and functional interference (31). Thus, it seemed
plausible that the fusion protein scTetR:HMGA1a would
circumvent this problem. We made use of a dimeric single-
chain (sc) tetR gene, which binds to tetO motifs as a single
molecule in contrast EBNA1:TetR, which binds as
homodimers (24).
The scTetR:HMGA1a protein was stably expressed in
EBNA1-positive HEK293 cells (Figure 2A), which were
transfected with plasmids carrying oriP wt (p3230), or two
diﬀerent hybrid replicon plasmids with 20 (tetO
20/DS
wt;
p3231) (Figure 2B) or 40 (tetO
40/DS
wt, p3293) copies of the
tetO motif (Table 1). All three plasmids carry a destabilized
GFP gene (32) as a short-lived phenotypic marker for
simple detection by ﬂuorescent-activate cell sorting
(FACS). The transfected cells were selected with hygro-
mycin for 19 days. At that time point (day 0) selection was
removed and the cells were further cultivated with or
without DOX for 12 days. GFP expression was determined
by FACS on days 0, 4, 8 and 12. Low-molecular weight
DNAs were isolated at three time points (day 0, 8 and 12)
and analyzed by Southern blot hybridization. DNAs were
also electroporated in E. coli in plasmid rescue experiments
to quantify the number of plasmid DNA molecules by
colony formation.
On day 0, the majority of the cells expressed GFP as
expected (Figure 2C, FACS data), and bonaﬁde plasmids
could be detected and quantiﬁed in plasmid rescue experi-
ments (Figure 2C, colony numbers) and by Southern blot
hybridization (Figure 2D). It was immediately apparent
that p3231 and p3293 plasmids (tetO
20/DS
wt and tetO
40/
DS
wt) were present at higher copy numbers than p3230
(oriP wt) (Figure 2D), although the cells did not express
higher amounts of GFP (Figure 2C). Upon removal of
selective pressure, GFP expression gradually diminished in
all samples and plasmid DNAs were gradually lost
(Figure 2C) as reported previously for oriP plasmids (33).
Very much in contrast, the hybrid replicon plasmids p3231
(tetO
20/DS
wt) and p3293 (tetO
40/DS
wt) were lost precipi-
tously in the presence of DOX (Figure 2D). Chromatin
immunoprecipitation experiments indicated that DOX
induced the loss of DNA binding of scTetR:HMGA1a
(but not EBNA1) within 4h (data not shown, Figure 2E).
When scTetR:HMGA1a rapidly dissociates from
tetO-binding sites the plasmid DNA molecules presumably
become instable and are lost during cell division or
degraded by nucleases. Relative signal strengths in
Southern blot analysis (Figure 2D and data not shown)
and colony numbers (Figure 2C) indicated that DOX-
induced plasmid loss was in the order of about factor
50–100 per week. Reduction of GFP expression appeared
not as dramatic but a substantial loss of GFP expression
could be documented (Figure 2C). DOX had a neglectable
eﬀect on p3230 (oriP wt). This and the two hybrid replicon
plasmids were stably maintained for 31 days under
hygromycin selection (Figure 2D and data not shown).
scTetR:HMGA1A confers DNA replication
We have previously shown that scTetR:HMGA1a recruits
ORC to DNA and confers plasmid DNA replication
similar to HMGA1a:EBNA1 (18). Toward this end we
had constructed hybrid oriP-like plasmid in which the four
EBNA1-binding sites that make up the DS element of oriP
were precisely replaced by four tetO sites such as in p3315
(FR
wt/tetO
4, Figure 3A, left panel, Table 1). In this
plasmid (and its derivatives, Table 1) all other ﬂanking
sequences that make the DS element remained untouched
including the three TRF2-binding sites, which can
inﬂuence eﬃcient initiation of DNA synthesis in oriP
(34). p3315 (FR
wt/tetO
4) and derivatives with tetO
4 multi-
mers (18) replicated faithfully in cells coexpressing both
EBNA1 and scTetR:HMGA1a. p3315 plasmid DNA was
only gradually lost in the presence of DOX over time in
contrast to oriP-like plasmid such as tetO
20/DS
wt or
tetO
40/DS
wt (compare Figure 2D and Figure 3B, left and
middle panels) indicating that plasmid retention is more
critical than DNA replication for the stable maintenance
of extrachromosomal DNA in proliferating cells.
Our experiments shown in Figure 2 indicated that
scTetR:HMGA1a can replace EBNA1 in order to eﬃ-
ciently retain extrachromosomal plasmid molecules. Our
previous data (18) and experiments shown in Figure 3B
proved that scTetR:HMGA1a can functionally confer
DNA replication of extrachromosomal plasmid DNA. In a
combinatorial approach, we generated synthetic plasmids,
which lack all EBNA1-binding sites but harbor tetO motifs
arranged in two clusters. tetO
20/tetO
4 (p3311) plasmid
DNA (Figure 3A, right panel) was introduced into EBNA1
and 12, cells were analyzed by FACS for the expression of plasmid-encoded GFP. Plasmid rescue experiments were performed on days 0, 8, and 12.
Low-molecular weight DNAs were prepared and cleaved with DpnI and 600ng of each DNA sample was electroporated into E. coli DH10B. The
absolute numbers of ampicillin-resistant colonies were calculated and shown in red as indicated (/+DOX). (D) Hybrid replicon plasmids are
maintained as plasmids in the absence but precipitously lost in the presence of DOX. As in C, p3230 (oriP wt) and two plasmids p3231 (tetO
20/DS
wt)
and p3293 (tetO
40/DS
wt) were transfected and selected. Low-molecular weight DNA was prepared on days 0, 8, and 12. DNA was also prepared
from the same cells, which had been kept under continuous hygromycin selection (HYG). The DNAs were digested with DpnI to multiply cleave
unreplicated DNAs and PmlI to cut cellular DNA, only. Southern blot hybridization were performed as in Figure 1C. The rightmost lane indicates
the migration pattern of 500pg E. coli-derived p3230 plasmid DNA indicating monomeric supercoiled, covalently closed and circular (ccc),
monomeric open circles (oc) and multimeric (mult.) forms of plasmid DNA. The ccc and oc form DNAs indicate the presence of extrachromosomal
plasmids for a period of 31 days throughout the entire experiment. Upon addition of DOX, the hybrid replicon plasmids were precipitously lost.
In the absence of DOX, they were maintained at higher copy numbers than wild-type oriP.( E) ChIP experiments indicate DOX-induced loss of
DNA binding of scTetR:HMGA1a but not EBNA1. From formaldehyde crosslinked chromatin of stably transfected cells as in C, EBNA1 and
scTetR:HMGA1a were immunoprecipitated and the precipitates were analyzed for coprecipitated plasmid DNA molecules by quantitative real-time
PCR. The histogram shows the results for p3231 (tetO
20/DS
wt) and p3230 (oriP wt) without or with DOX for 4h. The columns indicate the diﬀerence
between PCR data (mean values and standard deviations of three experiments) obtained with speciﬁc antibodies versus isotype control and
preimmune serum on a logarithmic y-axis.
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which were selected with hygromycin for 2–3 weeks.
p3311 plasmid DNA was maintained extrachromo-
somally as an artiﬁcial replicon comparable to oriP wt
and p3315 (FR
wt/tetO
4) (Figure 3C). Plasmid DNA of
p3311 became almost undetectable when, in the absence
of hygromycin selection, DOX was added for 7 days
(Figure 3B, right panel) whereas p3230 copy numbers
were not aﬀected (Figure 3B, middle panel). As expected,
synthetic, tetO
20/tetO
4 oriP-like plasmids replicated once
Figure 3. scTetR:HMGA1a mediates both chromatin tethering and DNA replication. (A) Schematic overview of the hybrid FR
wt/tetO
4 and synthetic
(tetO
20/tetO
4) replicon plasmids. (B) p3230 (oriP wt), p3315 (FR
wt/tetO
4) and p3311 (tetO
20/tetO
4) were stably transfected in HEK293 cells
expressing EBNA1+scTetR:HMGA1a; DNAs were prepared and digested with PmlI and HindIII. In the absence of hygromycin selection, addition
of doxycycline (+DOX) caused a modest reduction in the copy number of p3315, but a dramatic loss of p3311; the drug did not aﬀect p3230 copy
numbers as indicated by relative signal strengths in percent. Asterisks (
) indicate background signals. (C) p3230 (oriP wt), p3315 (FR
wt/tetO
4) and
p3311 (tetO
20/tetO
4) were stably introduced (sel.) as described in (B). Low-molecular weight DNAs were prepared, digested with PmlI and HindIII to
cleave both plasmid and cellular DNA (left) or PmlI (right) to cleave cellular DNA, only. Southern blot hybridization was performed as in
Figure 1C. All plasmids replicated and were maintained extrachromosomally as indicated by signals characteristic of covalently closed circles (ccc)
and open circles (oc) DNA molecules together with multimeric forms (mult.). (D) Synthetic, oriP-like plasmids replicate once per cell cycle in
Meselson–Stahl density transfer experiments. scTetR:HMGA1a-expressing HEK293 cells were stably transfected with p3230 (oriP wt) or p3421
(tetO
20/tetO
4) and newly synthesized DNA was labeled with 5-bromodeoxyuridine and separated on CsCl density equilibrium gradients. All DNAs
shifted from light, unlabeled DNA (1.70g/cm
3) to heavylight, hemisubstituted DNA (1.73g/cm
3). Plasmid DNA in the gradient fractions (left panel)
was quantiﬁed by real-time PCR in comparison with chromosomal DNA (right panel). The data indicate that wild-type oriP and synthetic oriP-like
plasmids replicated in synchrony with cellular DNA.
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oriP wt plasmid DNA in Meselson–Stahl density transfer
experiments (Figure 3D).
Conditional plasmid maintenance in cellsof different species
We constructed a prototypic all-in-one synthetic plasmid
p3333, which encompasses the two clusters of tetO sites
(tetO
20/tetO
4) and encodes scTetR:HMGA1a (Figure 4A).
p3333 also carries a selectable marker gene, which confers
resistance against hygromycin in transduced cells. p3333
was stably introduced into three diﬀerent human cell lines
including HEK293 cells, ﬁbroblasts (143/tk
) and B cells
(Akata 27, an EBV-negative derivative of Akata cells).
Rat-1 cells, a murine ﬁbroblast cell line, were also
included, in which small and middle-sized oriP plasmids
cannot be stably maintained as indicated in Figure 4B.
The transduced cells were selected with hygromycin for
2–3 weeks, when the selective pressure was alleviated. In
all four cell lines and in the absence of selection (DOX),
p3333 was maintained at stable copy numbers; they were
dramatically reduced or became undetectable upon addi-
tion of doxycycline (+DOX) within 1 week (Figure 4B).
In case of Rat-1 cells we cannot exclude the possibility
that part of the detected signals might stem from tandemly
integrated p3333 DNA. Previously, similar experiments
have been overinterpreted but it is apparent that the signal
strength of p3333 DNA is considerably diminished in the
presence of DOX, which can only result from the loss of
non-integrated, extrachromomal plasmid molecules.
DISCUSSION
For the ﬁrst time we have established extrachromosomal
gene vector plasmids, whose maintenance can be con-
trolled in cis by a small-molecular weight compound. The
independent and separable functions of the oriP elements
DS and FR individually dedicated to DNA replication
and nuclear replicon retention (reviewed in 11,19,35,36)
indicate that EBNA1 plays a dual but distinct role when it
binds to either DS or FR. Our combinatorial approach
support that view. Synthetic, oriP-like tetO
20/tetO
4
plasmids such as p3311 and p3333 replicated and were
maintained extrachromosomally long term. DOX, which
abrogated binding of EBNA1:TetR or scTetR:HMGA1a
to tetO motifs (Figure 2E and data not shown), induced
rapid loss of plasmid DNAs presumably by nuclease
degradation. In contrast, plasmids in which only the DS
element was replaced by tetO
4 such as p3315 (FR
wt/tetO
4)
were passively lost after addition of DOX because they do
not replicate in the presence of this drug (18). Our
observations suggest that the attachment of plasmid DNA
molecules to the host cell chromatin is more critical for
plasmid stability than DNA replication.
Because these synthetic oriP-like plasmids rely solely on
TetR fusions proteins and do not require EBNA1 they are
virtually non-viral in terms of their plasmid features
(Figure 4). Our results also support HMGA1a as a cellular
protein that can functionally replace EBNA1 with respect
to its central contribution(s) to DNA replication
(18,19,37,38). This ﬁnding indicates that HMGA1a
could be a cellular candidate of the factor that fosters
ORC’s recognition of replication origins in mammalian
genomes (18).
Tetracycline-regulated gene expression has been demon-
strated in vivo (39) indicating that gene vectors, which can
be regulated in cis are likely to be functional in vivo as well.
Mutants of the tetR gene with a reverse phenotype bind to
Figure 4. Stable maintenance and induced loss of an all-in-one synthetic
oriP-like plasmid. (A) Genetic map of p3333, the cis-acting replicon and
the trans-acting factor scTetR:HMGA1a are indicated together with the
marker genes encoding destabilized GFP and hygromycin B phospho-
transferase. (B) The vector plasmid p3333 replicates and is maintained
extrachromosomally in four diﬀerent cell lines in a DOX-dependent
manner. As expected the oriP plasmid pHEBNA (49) (p3323, Table 1)
does not stably replicate in Rat-1 murine cells.
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and are expected to be functional in our system, too. We
assume that TetR fusions with the reverse phenotype
would allow establishment of oriP-like plasmids only in
the presence of tetracycline or its derivatives, which is an
even more stringent condition for plasmid gene vectors
regulated in cis.
We have developed a ﬁrst generation of gene vector
plasmids, which can be regulated in cis. Such gene vector
plasmids can also be packaged into a viral particle if the
necessary packaging signals are provided (42–44). Addi-
tional genes of interest (Figure 4) or even gene loci of
therapeutic interest can be added because the packaging
capacity of DNA-based plasmid vectors or viral vectors
can be large, exceeding 100kb (45,46 and references
therein). Somatic gene and immune therapy are in need of
gene vector systems, which are maintained long term, can
be controlled by simple means and do not alter the
recipient cell(s) genetically (8,47). Our novel gene vector
system oﬀers such advantages and should contribute to
the feasibility of innovative therapeutic approaches in
the future.
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